Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0400 Transporter Info
Gene Name	SLC55A1
Transporter Name	Mitochondrial proton/calcium exchanger protein
Gene ID	3954
UniProt ID	O95202

Post-Translational Modification of This DT
Overview of SLC55A1 Modification Sites with Functional and Structural Information
Sequence	M A S I L L R S C R G R A P A R L P P P P R Y T V P R G S P G D P A H L S C A S T L G L R N C L N V P F G C C T P I H P V Y T S S R G D H L G C W A L R P E C L R I V S R A P W T S T S V G F V A V G P Q C L P V R G W H S S R P V R D D S V V E K S L K S L K D K N K K L E E G G P V Y S P P A E V V V K K S L G Q R V L D E L K H Y Y H G F R L L W I D T K I A A R M L W R I L N G H S L T R R E R R Q F L R I C A D L F R L V P F L V F V V V P F M E F L L P V A V K L F P N M L P S T F E T Q S L K E E R L K K E L R V K L E L A K F L Q D T I E E M A L K N K A A K G S A T K D F S V F F Q K I R E T G E R P S N E E I M R F S K L F E D E L T L D N L T R P Q L V A L C K L L E L Q S I G T N N F L R F Q L T M R L R S I K A D D K L I A E E G V D S L N V K E L Q A A C R A R G M R A L G V T E D R L R G Q L K Q W L D L H L H Q E I P T S L L I L S R A M Y L P D T L S P A D Q L K S T L Q T L P E I V A K E A Q V K V A E V E G E Q V D N K A K L E A T L Q E E A A I Q Q E H R E K E L Q K R S E V A K D F E P E R V V A A P Q R P G T E P Q P E M P D T V L Q S E T L K D T A P V L E G L K E E E I T K E E I D I L S D A C S K L Q E Q K K S L T K E K E E L E L L K E D V Q D Y S E D L Q E I K K E L S K T G E E K Y V E E S K A S K R L T K R V Q Q M I G Q I D G L I S Q L E M D Q Q A G K L A P A N G M P T G E N V I S V A E L I N A M K Q V K H I P E S K L T S L A A A L D E N K D G K V N I D D L V K V I E L V D K E D V H I S T S Q V A E I V A T L E K E E K V E E K E K A K E K A E K E V A E V K S
PTM type	X-Acetylation X-Glutathionylation X-Malonylation X-Methylation X-Oxidation X-Phosphorylation X-S-glutathionylation X-S-nitrosylation X-S-sulfhydration X-Succinylation X-Sulfoxidation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	162
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC55A1 Lysine 162 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	257
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC55A1 Lysine 257 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC55A1			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	284
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC55A1 Lysine 284 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC55A1			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	463
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC55A1 Lysine 463 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC55A1			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	597
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC55A1 Lysine 597 has the potential to affect its expression or activity.
Glutathionylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at SLC55A1 Cystine 330 has the potential to affect its expression or activity.
Malonylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC55A1 Lysine 373 has the potential to affect its expression or activity.
Methylation
Arginine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[7]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	307
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC55A1 Arginine 307 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[7]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	393
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC55A1 Arginine 393 has the potential to affect its expression or activity.
Oxidation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence LETM1			[8]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at LETM1 Cystine 203 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence LETM1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at LETM1 Cystine 330 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence LETM1			[8]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at LETM1 Cystine 379 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence LETM1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	552
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at LETM1 Cystine 552 has the potential to affect its expression or activity.
Phosphorylation
Serine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	118
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 118 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 123 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC55A1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	126
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 126 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC55A1			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	142
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 142 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC55A1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	190
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 190 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	238
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 238 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	244
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 244 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC55A1			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	287
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 287 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 428 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC55A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	435
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 435 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC55A1			[10] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 549 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC55A1			[10] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	553
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 553 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC55A1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	561
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 561 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC55A1			[18] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	666
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 666 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC55A1			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	739
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Serine 739 has the potential to affect its expression or activity.
Threonine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[15] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 175 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	192
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 192 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 239 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	242
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 242 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 426 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	436
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 436 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC55A1			[17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	439
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 439 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC55A1			[19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	541
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 541 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC55A1			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	563
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 563 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC55A1			[22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	713
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Threonine 713 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	141
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Tyrosine 141 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC55A1 Tyrosine 422 has the potential to affect its expression or activity.
S-glutathionylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence LETM1			[25]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at LETM1 Cystine 330 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence LETM1			[26]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at LETM1 Cystine 203 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence LETM1			[27]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at LETM1 Cystine 330 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence LETM1			[26]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	552
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at LETM1 Cystine 552 has the potential to affect its expression or activity.
S-sulfhydration
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence LETM1			[28]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at LETM1 Cystine 330 has the potential to affect its expression or activity.
Succinylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[1] , [29]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at SLC55A1 Lysine 373 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[30]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC55A1 Methionine 271 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[30]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	306
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC55A1 Methionine 306 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC55A1			[30]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC55A1 Methionine 421 has the potential to affect its expression or activity.
Ubiquitination
Arginine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[18] , [31]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	112
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Arginine 112 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[32]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	180
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Arginine 180 has the potential to affect its expression or activity.
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[32]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Glutamicacid 313 has the potential to affect its expression or activity.
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC55A1			[33]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	257
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 257 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC55A1			[34]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 292 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC55A1			[32]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	360
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 360 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC55A1			[33]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 373 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC55A1			[32]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	493
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 493 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC55A1			[33]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	682
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC55A1 Lysine 682 has the potential to affect its expression or activity.

References
1	Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
2	Methods and evaluation of the polygraphic recording of the nocturnal sleep. Comprehensive review. Cesk Neurol Neurochir. 1975 Mar;38(2):110-5.
3	Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow. Mol Cell Proteomics. 2015 Sep;14(9):2429-40.
4	Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
5	In vivo tagging and characterization of S-glutathionylated proteins by a chemoenzymatic method. Angew Chem Int Ed Engl. 2012 Jun 11;51(24):5871-5.
6	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
7	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: LETM1_HUMAN)
8	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
9	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
10	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
11	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
12	Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
13	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
14	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
15	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
16	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
17	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
18	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
19	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
20	Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.
21	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
22	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
23	HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. Blood. 2017 Feb 2;129(5):598-608.
24	Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival. Proc Natl Acad Sci U S A. 2016 May 17;113(20):5688-93.
25	dbGSH: a database of S-glutathionylation. Bioinformatics. 2014 Aug 15;30(16):2386-8.
26	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
27	Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
28	Direct Proteomic Mapping of Cysteine Persulfidation. Antioxid Redox Signal. 2020 Nov 20;33(15):1061-1076.
29	Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 2013 Aug 29;4(4):842-51.
30	Redox proteomics of protein-bound methionine oxidation. Mol Cell Proteomics. 2011 May;10(5):M110.006866.
31	Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012 Oct;14(10):1089-98.
32	A COFRADIC protocol to study protein ubiquitination. J Proteome Res. 2014 Jun 6;13(6):3107-13.
33	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
34	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence